69
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Preliminary in vivo studies of a new lecithin-based formulation of paclitaxel

, , , &
Pages 588-592 | Received 18 Oct 2008, Accepted 24 Oct 2008, Published online: 05 Nov 2009
 

Abstract

Amorphous paclitaxel dissolves rapidly (1 mg mL−1) in an isotonic aqueous dispersion of egg lecithin (5% w/w), a new biocompatible submicron drug carrier consisting of structured aggregates with average size 0.5 µm. The solution is physically stable for at least 24 h and can be administered as an intravenous infusion. After a 5 h infusion in rabbits (0.66 mg kg−1 h−1), changes in blood morphology were comparable to those observed in rabbits that received the commercial product Taxol®. No changes in the enzyme profiles (alanine/aspartate aminotransferase or alkaline phosphatase) were observed. However, during infusion of the new formulation plasma concentration of paclitaxel (292 ± 182 ng mL−1) was lower than observed after Cremophor-containing Taxol® (540 ± 262 ng mL−1). This result may indicate that the tissue distribution is different for the two drug formulations. Daily intraperitoneal administrations (3 doses/day) in mice demonstrated that the new carrier solution was non-toxic and, relative to Taxol, the new formulation exhibited similar or less toxicity.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.